Cosentyx wins EU approval for first-line paediatric psoriasis

3rd August 2020 Uncategorised 0

Low-dose and high-dose Cosentyx is effective in rapidly improving skin symptoms and quality of life

More: Cosentyx wins EU approval for first-line paediatric psoriasis
Source: News